Information Provided By: 
Fly News Breaks for March 10, 2016
AGN, SUPN
Mar 10, 2016 | 07:49 EDT
SunTrust says that a federal court's Markman ruling for Supernus' (SUPN) patent lawsuit against Allergan (AGN) was largely favorable to Supernus. The firm thinks there is "a high probability" that Supernus will prevail if the case goes to trial and that any settlement would be more favorable to Sueprnus than Allergan. The firm thinks that a settlement would delay the entry of a generic version of topiramate until April 2025. SunTrust keeps a Buy rating on Supernus.
News For SUPN;AGN From the Last 2 Days
There are no results for your query SUPN;AGN
